Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial. (Record no. 22945317)

MARC details
000 -LEADER
fixed length control field 02327 a2200673 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250516162053.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201311s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1474-5488
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/S1470-2045(13)70310-3
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Garassino, Marina Chiara
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20131104
245 00 - TITLE STATEMENT
Title Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. The Lancet. Oncology
Date of publication, distribution, etc. Sep 2013
300 ## - PHYSICAL DESCRIPTION
Extent 981-8 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged, 80 and over
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Agents
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Carcinoma, Non-Small-Cell Lung
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Disease-Free Survival
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Docetaxel
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element ErbB Receptors
General subdivision antagonists & inhibitors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Erlotinib Hydrochloride
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Lung Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Mutation
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Protein Kinase Inhibitors
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Proto-Oncogene Proteins
General subdivision genetics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Proto-Oncogene Proteins p21(ras)
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Quinazolines
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Taxoids
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element ras Proteins
General subdivision genetics
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Martelli, Olga
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Broggini, Massimo
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Farina, Gabriella
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Veronese, Silvio
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Rulli, Eliana
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Bianchi, Filippo
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Bettini, Anna
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Longo, Flavia
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Moscetti, Luca
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Tomirotti, Maurizio
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Marabese, Mirko
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ganzinelli, Monica
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lauricella, Calogero
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Labianca, Roberto
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Floriani, Irene
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Giaccone, Giuseppe
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Torri, Valter
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Scanni, Alberto
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Marsoni, Silvia
773 0# - HOST ITEM ENTRY
Title The Lancet. Oncology
Related parts vol. 14
-- no. 10
-- p. 981-8
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1016/S1470-2045(13)70310-3">https://doi.org/10.1016/S1470-2045(13)70310-3</a>
Public note Available from publisher's website

No items available.